Louis Lucido
President at BIOCORRX INC.
Net worth: 2 M $ as of 29/04/2024
Louis Lucido active positions
Companies | Position | Start | End |
---|---|---|---|
BIOCORRX INC. | Director/Board Member | 28/02/2019 | - |
President | 30/01/2024 | - | |
Independent Dir/Board Member | 28/02/2019 | 30/01/2024 | |
Court Appointed Special Advocates of Los Angeles | Chairman | - | - |
Director/Board Member | 29/06/2019 | - | |
Doubleline Leveraged Fund Ltd.
Doubleline Leveraged Fund Ltd. Financial ConglomeratesFinance Doubleline Leveraged Fund Ltd. operates as a pooled investment fund. The company is headquartered in Los Angeles, CA. | Director/Board Member | - | - |
DoubleLine Leveraged Fund LP
DoubleLine Leveraged Fund LP Investment Trusts/Mutual FundsMiscellaneous DoubleLine Leveraged Fund LP operates as a investment fund. The company is headquartered in Los Angeles, CA. | Director/Board Member | - | - |
Doubleline Opportunistic Income Fund Ltd.
Doubleline Opportunistic Income Fund Ltd. Investment Trusts/Mutual FundsMiscellaneous Doubleline Opportunistic Income Fund Ltd. provides pooled Investment firm. The company is headquartered in Los Angeles, CA. | Director/Board Member | - | - |
Junior Achievement of Southern California | Director/Board Member | 31/05/2013 | - |
826LA | Director/Board Member | 31/05/2013 | - |
Lupus Research Alliance, Inc.
Lupus Research Alliance, Inc. Miscellaneous Commercial ServicesCommercial Services Lupus Research Alliance, Inc. provides research and development for the treatment of lupus disease. The company is headquartered in New York, NY. | Director/Board Member | 30/06/2016 | - |
BioCorRx Pharmaceuticals, Inc.
BioCorRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of BioCorRx, Inc., BioCorRx Pharmaceuticals, Inc. is a biopharmaceutical company specializing in developing treatments for substance use disorder. The company is based in Anaheim, CA. The lead candidate is a naltrexone pellet implanted subcutaneously being developed to address both opioid and alcohol use disorders. The company is seeking FDA approval of the naltrexone pellet and exploring other products for regulatory approval. The CEO is Brady James Granier, and the company was founded by Lourdes Felix. | Director/Board Member | 30/01/2024 | - |
President | 30/01/2024 | - |
Career history of Louis Lucido
Former positions of Louis Lucido
Companies | Position | Start | End |
---|---|---|---|
░░░ ░░░░░░░ ░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░ ░░░░░ ░░░░░░░░░░ ░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░ ░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - | - |
Training of Louis Lucido
New York University | Masters Business Admin |
Statistics
International
United States | 18 |
Canada | 2 |
Operational
Director/Board Member | 9 |
Chairman | 2 |
Chief Operating Officer | 2 |
Sectoral
Finance | 6 |
Miscellaneous | 5 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
BIOCORRX INC. | Health Services |
AZN CAPITAL CORP. | Non-Energy Minerals |
Private companies | 15 |
---|---|
TCW Asset Management Co. LLC
TCW Asset Management Co. LLC Investment ManagersFinance TCW Asset Management Co. LLC (TCW) is a SEC-registered investment advisor headquartered in Los Angeles, California. The firm was founded in 1992 and is wholly-owned by The TCW Group, Inc. In 2013, TCW management and private investment funds affiliated with The Carlyle Group (NASDAQ: CG) acquired TCW Group from Société Générale. TCW provides investment management and advice for a wide array of investment strategies for institutional and individual investors through investment advisory accounts, private open- and closed-end commingled investment funds and structured investment vehicles such as collateralized debt obligations. | Finance |
Junior Achievement of Southern California | |
Hyperion Brookfield Asset Management, Inc.
Hyperion Brookfield Asset Management, Inc. Investment ManagersFinance Hyperion Capital Management, Inc. is an investment advisory firm located in New York City that offers a range of investment management services for institutional investors. | Finance |
DoubleLine Capital LP
DoubleLine Capital LP Investment ManagersFinance DoubleLine Capital LP (DoubleLine) is an independent, SEC-registered investment advisor headquartered in Tampa, Florida. The firm was founded by Jeffrey Gundlach and Louis Lucido in 2009. DoubleLine provides a variety of investment management services to institutional clients such as corporate entities, pension plans, Undertakings for the Collective Investment of Transferable Interests (UCITS) funds, registered investment companies and unregistered investment companies, foundations, and public and government entities. | Finance |
Lupus Research Alliance, Inc.
Lupus Research Alliance, Inc. Miscellaneous Commercial ServicesCommercial Services Lupus Research Alliance, Inc. provides research and development for the treatment of lupus disease. The company is headquartered in New York, NY. | Commercial Services |
Doubleline Opportunistic Credit Fund
Doubleline Opportunistic Credit Fund Investment Trusts/Mutual FundsMiscellaneous Doubleline Opportunistic Credit Fund operates as a closed-end investment fund or investment trust. The firm invests in debt securities and income-producing investments of any kind, including, without limitation, residential and commercial mortgage-backed securities, asset-backed securities, the United States Government securities, corporate debt, international sovereign debt, and short-term investments. Its investment objective is to seek high total investment return by providing a high level of current income and the potential for capital appreciation. The company was founded on July 22, 2011 and is headquartered in Los Angeles, CA. | Miscellaneous |
826LA | |
Delphi Financial Group, Inc.
Delphi Financial Group, Inc. Investment ManagersFinance Delphi Financial Group, Inc. is an investment advisor headquartered in Wilmington, Delaware. The firm is a subsidiary of Tokio Marine & Nichido Fire Insurance Co., Ltd., itself a subsidiary of Tokio Marine Holdings, Inc. (TYO: 8766) in Japan. Delphi Financial Group was founded by Robert Rosenkranz in 1987 and act as a financial holding firm focused on specialty insurance and insurance-related service businesses in North America. | Finance |
DoubleLine Income Solutions Fund
DoubleLine Income Solutions Fund Investment Trusts/Mutual FundsMiscellaneous DoubleLine Income Solutions Fund is a non-diversified, closed-end management investment company, which engages in the investment to a portfolio of investments selected for their potential to provide high current income, growth of capital, or both. Its investment objective is to provide a high level of current income and its secondary objective is to seek capital appreciation. The company was founded on January 10, 2013 and is headquartered in Los Angeles, CA. | Miscellaneous |
Court Appointed Special Advocates of Los Angeles | |
Doubleline Opportunistic Income Fund Ltd.
Doubleline Opportunistic Income Fund Ltd. Investment Trusts/Mutual FundsMiscellaneous Doubleline Opportunistic Income Fund Ltd. provides pooled Investment firm. The company is headquartered in Los Angeles, CA. | Miscellaneous |
DoubleLine Leveraged Fund LP
DoubleLine Leveraged Fund LP Investment Trusts/Mutual FundsMiscellaneous DoubleLine Leveraged Fund LP operates as a investment fund. The company is headquartered in Los Angeles, CA. | Miscellaneous |
Doubleline Leveraged Fund Ltd.
Doubleline Leveraged Fund Ltd. Financial ConglomeratesFinance Doubleline Leveraged Fund Ltd. operates as a pooled investment fund. The company is headquartered in Los Angeles, CA. | Finance |
DoubleLine Group LP | |
BioCorRx Pharmaceuticals, Inc.
BioCorRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of BioCorRx, Inc., BioCorRx Pharmaceuticals, Inc. is a biopharmaceutical company specializing in developing treatments for substance use disorder. The company is based in Anaheim, CA. The lead candidate is a naltrexone pellet implanted subcutaneously being developed to address both opioid and alcohol use disorders. The company is seeking FDA approval of the naltrexone pellet and exploring other products for regulatory approval. The CEO is Brady James Granier, and the company was founded by Lourdes Felix. | Health Technology |
- Stock Market
- Insiders
- Louis Lucido
- Experience